Sevoflurane → Sevoflurane

HRID 15692

반응식

HRID 15692 반응식
[CH2:1]([F:12])[O:2][CH:3]([C:8]([F:11])([F:10])[F:9])[C:4]([F:7])([F:6])[F:5]>O>[CH2:1]([F:12])[O:2][CH:3]([C:4]([F:7])([F:5])[F:6])[C:8]([F:9])([F:11])[F:10].[CH:3]([OH:2])([C:8]([F:11])([F:10])[F:9])[C:4]([F:7])([F:6])[F:5]

참가 물질

4

실험 절차

The steps of combining the crude sevoflurane with water in an amount sufficient to produce a multiphase mixture comprising an aqueous phase and a sevoflurane phase, contacting the aqueous phase and the sevoflurane phase with each other under conditions and for a time sufficient to extract at least a portion of the HFIP from the sevoflurane phase into the aqueous phase, and separating the phases of the multiphase mixture without fractional distillation, may, if necessary, be repeated. Purified sevoflurane comprising an acceptable amount of HFIP is then isolated. The removal of HFIP from the crude sevoflurane occurs without contacting the crude sevoflurane with an aqueous basic solution.

후처리

  1. customto produce a multiphase mixture
  2. extractionthe sevoflurane phase with each other under conditions and for a time sufficient to extract at least a portion of the HFIP from the sevoflurane phase into the aqueous phase
  3. customseparating the phases of the multiphase mixture
  4. distillationwithout fractional distillation

출처 및 근거

ORD 기록
ord-8af87598142a452492a12f735d884d3e
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07732647B2

연결된 노트

불러오는 중…